the role of homocvsteine in the concept of prevention of coronary heart disease;Stellenwert des homocysteins im präventionskonzept der koronaren herzkrankheit

Herz Kreislauf

Volumn 29, Issue 7-8, 1997, Pages 213-218

  Mock, B ^a,b   Weltermann, B ^b   Prinz Langenohl, R ^b,c   Hopp, H W ^a,b   Pietrzik, K ^a,b,c  

^a Institut fur Ernahrungswissenschaft   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Coronary artery disease; Folic acid; Homocysteine; Prevention

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ARTICLE; CORONARY ARTERY DISEASE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; RISK FACTOR; SMOKING;

EID: 0030764003     PISSN: 00467324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ackermann-Liehricli, U, Gutzwiller, F., Keil, U, Kunze, M. Epidemiologie. 2. Auflage, Meducation Foundation, Cham 1990
2. Assmann, G. Lipidstoffwechsel und Atherosklerose. Schattauer, Stuttgart-New York 1982
3. Boushey. C. J., Beresford, S. A. A., Omenn, G. S., Motulsky, A. G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274,1049-1057 ( 1995)
4. Brattstrom, L., Israelsson, B., Norrving, B., Bergqvist. D., Turne, l, Hultberg, B., Hamfeld, A. Impaired homocysteine metabolism in early-onset cerebral and peripheral arterial occlusive disease. Atherosclerosis 81,51 -60 ( 1990)
5. Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalanne, S., Fowler, B., Graham, I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 324.1149-1155 (1991)
6. Deutsche Gesellschaft für Ernährung (Hrsg.): Empfehlungen für die Nährstoffzufuhr. Umschau-Verlag, Frankfurt/Main 1991
7. Dierkes, J. Vitamin requirements for the reduction of homocysteine blood levels. Wissenschaftlicher Fachverlag Dr. Fleck, Giessen 1995
8. Dudman, N. P. B., Wilcken, D. E. L. Increased plasma copper in patients with homocysteinuria due to cystathionine synthasc deficiency. Clin. Chim. Acta 127,105-113 (1983)
9. Evans, A. S. Causation and disease: the HenleKoch-postulates revisited. Y. J. Biol. Med. 49, 175-195(1976)
10. Harker, L. A., Ross, R., Slichter. S. J., Scott, C. R. Homocysteine-induced atherosclerosis. The role of endothelial cell injury and platelet response in its genesis. J. Clin. Invest. 58,731-741 (1976)
11. Harpel, P. C, Chang, V. T., Borth, W. Homocysteine and other sulfhydryl compounds enhance the binding of lipoproteine(a) to fibrin: A potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. Proc. Natl. Acad. Sei. USA 89, 10193-10197 (1992)
12. Heinecke, J. W., Rosen, H., Suzuki. L. A., Chait, A. The role of sulfur-containing amino acids in Superoxide production and modification of lowdensity lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 262,10Ü98-10103 (1987)
13. Kassenärztliche Vereinigung Nordrhein (Hsrg.): Ärzte-Verzeichnis. Deutscher Ärzte-Verlag, Köln 1994
14. Lentz, S. R., Sadler, J. E. Inhibition of thrombomodulin surface expression and protein C activation by thrombogenic agent homocysteine. J. Clin. Invest. 88,1906-1912 (1991)
15. Mausner, J., Kramer, S. Epidemiology. 2nd ed. W. B. Saunders Company, Philadelphia 1985
16. Mayer, E. L., Jacobsen, D. W., Robinson, K. Homocysteine and coronary atherosclerosis. J. Am. Coll. Card. 27,517-527 (1996)
17. McCully, K. S. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am. J. Pathol. 56,111-122 (1969)
18. Mudd, S. H., Levy, H. L., Skovby, F. Disorders of transsulfuration. In Scriver, C. S., Beaudet, A. L., Sly, W. L., Valle, D. (Hrsg.): The metabolic basis of inherited disease. McGraw-Hill International Book Co., New York 1989, S. 693-734
19. Pancharuniti, N., Lewis, C. A., Sauberlich. H. E., Perkins, L. L., Go, R. C. P., Gore, T. B., Cornwell, P. E., Roseman, J. M. Plasma homocyst(e)ine, folate, and vitamin B12 concentrations and risk for early-onset coronary artery disease. Am. J. Clin. Nutr. 59,940-948 (1994)
20. Rodgers, G. M., Kane, W. H. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator, i. Clin. Invest. 77, 1909-1916(1986)
21. Rodgers. G. M., Conn, M. T. Homocysteine. an atherogenic stimulus reduces protein C activation by arterial and venous endothelial cells. Blood 75. 895-901(1990)
22. Sauberlich, H. E. Evaluation of folate nutrition in population groups. In Picciano. M. F., Stokstad, E. L. R., Gregory III, J. F. (Hrsg.): Folie acid metabolism in health and disease. 1. Auflage. WileyLiss, New York 1990, S. 211-235
23. Selhub. J., Jacques, P. F., Wilson, P. W. F., Rush. D., Rosenberg, I. H. Vitamin status and intake as primary determinants of homocysteinaemia in an elderly population. JAMA 270,2693-2698 (1993)
24. Stabler. S. P., Marcell, P. D., Podell. E. R., Allen, R. H., Savage, D. G., Lindenbaum, J. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectometry. J. Clin. Invest. 81,466-474 ( 1988)
25. Stampfer, M. J., Malinow, M. R., Willett, W. C., Newcomer. L. M., Upson, B., Ullmann. D., Tishler, P. V, Hennekens. C. H. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268, 877-881 (1992)
26. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., Witzum, J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenecity. N. Engl. J. Med. 320, 915-924(1989)
27. Ubbink, J. B., Vermaak, W. J. H., Bennett, J. M., Becker, P. J., Staden, van D. A., Bissbort, S. The prevalence of homocysteinemia and hypercholesterinemia in angiographically defined coronary artery disease. Klin. Wochenschr. 69, 527-534 (1991)
28. Ubbink, J. B., Vermaak, W. J. H., Merwe, A.v.d., Becker, P. J., Delport, R., Potgieter, H. C: Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J. Nutr. 124,1927-1933 (1994)
29. Wu, L. L., Wu, 1, Hunt, S. C., James, B. C., Vincent, G. M., Wiliams, R. R., Hopkins, P. N. Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin. Chem. 40, 552-561 (1994)